Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19

SHANGHAI, China, Sept. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (FDA) has expanded the emergency use

Read More

Marawi infra projects 80% complete

The government-led rehabilitation efforts in Marawi City is already 80-percent complete, Task Force Bangon Marawi (TFBM) chairperson and housing czar Secretary Eduardo Del Rosario said on Sunday.

Despite the challenges posed by the health crisis and inclement weather, del Rosario assured all infrastructure projects will …

Read More